Laurion Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-27,095
| Closed | -$201K | – | 512 |
|
|
2021
Q3 | $201K | Sell |
27,095
-1,067,841
| -98% | -$7.92M | ﹤0.01% | 388 |
|
|
2021
Q2 | $15.9M | Buy |
1,094,936
+390,328
| +55% | +$5.67M | 0.09% | 49 |
|
|
2021
Q1 | $14.4M | Buy |
704,608
+63,373
| +10% | +$1.29M | 0.08% | 98 |
|
|
2020
Q4 | $11.4M | Buy |
641,235
+621,754
| +3,192% | +$11M | 0.09% | 50 |
|
|
2020
Q3 | $288K | Sell |
19,481
-224,990
| -92% | -$3.33M | ﹤0.01% | 496 |
|
|
2020
Q2 | $5.13M | Sell |
244,471
-55,529
| -19% | -$1.17M | 0.06% | 65 |
|
|
2020
Q1 | $6.93M | Buy |
300,000
+222,472
| +287% | +$5.14M | 0.08% | 79 |
|
|
2019
Q4 | $2.01M | Buy |
+77,528
| New | +$2.01M | 0.02% | 132 |
|
|
2018
Q3 | – | Sell |
-61,110
| Closed | -$1.39M | – | 1107 |
|
|
2018
Q2 | $1.39M | Sell |
61,110
-219,945
| -78% | -$4.99M | 0.01% | 451 |
|
|
2018
Q1 | $6.82M | Buy |
+281,055
| New | +$6.82M | 0.05% | 119 |
|
|
2014
Q4 | – | Sell |
-74,370
| Closed | -$1.71M | – | 333 |
|
|
2014
Q3 | $1.71M | Sell |
74,370
-50,502
| -40% | -$1.16M | 0.04% | 63 |
|
|
2014
Q2 | $3.98M | Buy |
+124,872
| New | +$3.98M | 0.08% | 37 |
|